Objective Evaluate properties of outcome measures for gluteal tendinopathy. Design Multistage scoping/systematic review. Data sources Cochrane, PubMed, Embase, Scopus, Web of Science, PEDro, CINAHL, SPORTDISCUS were searched (December 2021) to identify measures used to evaluate gluteal tendinopathy. Measures were mapped to the core health domains for tendinopathy. Medline, CINAHL, Embase and PubMed were searched (December 2021) for studies evaluating measurement properties of gluteal tendinopathy outcome measures captured in the initial search. Both reviews included studies that evaluated a treatment in participants with gluteal tendinopathy, diagnosed by a professional. Consensus-based-Standards for the Selection of Health Instruments methodology were followed—including bias assessment and synthesis of findings. Results Six studies reported on the Victorian Institute of Sport Assessment—Gluteal Tendinopathy (VISA-G). One study reported on the Hip Outcome Score (HOS)—activities of daily living (ADL) and Sport. The VISA-G had moderate-quality evidence of sufficient construct validity (known group) and responsiveness (pre–post intervention), low-quality evidence of sufficient reliability, measurement error, comprehensibility and insufficient construct validity (convergent), and very low-quality evidence of sufficient comprehensiveness, relevance and responsiveness (comparison with other outcome measures). Both the HOS(ADL) and HOS(Sport) had very low-quality evidence of sufficient reliability, relevance and insufficient construct validity and comprehensiveness. The HOS(ADL) had very low-quality evidence of sufficient comprehensibility and insufficient measurement error. The HOS(Sport) had very low quality evidence of inconsistent comprehensibility and sufficient measurement error. Conclusion Rigorously validated outcome measures for gluteal tendinopathy are lacking. The VISA-G is the preferred available option to capture the disability associated with gluteal tendinopathy.

中文翻译：

---

臀肌腱病管理中的结果测量：对其测量特性的系统评价

目的 评估臀肌腱病结局指标的特性。设计多阶段范围界定/系统审查。对数据源 Cochrane、PubMed、Embase、Scopus、Web of Science、PEDro、CINAHL、SPORTDISCUS 进行了搜索（2021 年 12 月），以确定用于评估臀肌腱病的措施​​。测量被映射到肌腱病的核心健康领域。对 Medline、CINAHL、Embase 和 PubMed 进行了搜索（2021 年 12 月），以查找评估初始搜索中获得的臀肌腱病结果测量的测量特性的研究。两篇综述都包括评估由专业人士诊断的臀肌腱病患者的治疗方法的研究。遵循基于共识的卫生工具选择标准方法——包括偏差评估和结果的综合。结果 六项研究报告了维多利亚运动评估研究所 - 臀肌腱病 (VISA-G)。一项研究报告了髋关节结果评分（HOS）——日常生活活动（ADL）和运动。VISA-G 具有足够的结构效度（已知组）和响应性（干预前后）的中等质量证据，具有足够可靠性、测量误差、可理解性和结构效度不足（收敛）的低质量证据，以及非常低质量的证据。充分全面性、相关性和响应性的质量证据（与其他结果测量的比较）。HOS(ADL) 和 HOS(Sport) 都具有非常低质量的证据，证明有足够的可靠性、相关性和不足的结构效度和全面性。HOS(ADL) 的证据质量非常低，表明其具有足够的可理解性和不足的测量误差。HOS(Sport) 的可理解性和足够的测量误差质量非常低。结论 缺乏经过严格验证的臀肌腱病结局指标。VISA-G 是捕捉与臀肌腱病相关的残疾的首选可用选项。